Skip to main content
Have a personal or library account? Click to login
Impact of superdisintegrants on efavirenz release from tablet formulations Cover

Impact of superdisintegrants on efavirenz release from tablet formulations

Open Access
|Dec 2010

References

  1. S. Sathigari, G. Chadha, Y-H. Lee, N. Wright, D. Parsons, V. Rathnagiri, O. Fasina and R. Babu, Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes,(2009) 81-87; DOI: 10.1208/S12249-008-9180-3.
  2. K. Kesavan, V. U. Rao, K. Bindu, P. S. Rajinikanth, J. K. Pandit and J. Balasubramaniam, Immediate release tablets of valsartan and efavirenz: Role of concentration of superdisintegrant,(2008) 229-243.
  3. W. T. Makooi-Morehead, J. D. Buehlar and B. R. Landmann, Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants, US Pat. 6,238,695 B1, 29 May 2001;
  4. N. Zhao and L. L. Augsburger, The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressible tablets,(2005) E120-126.
  5. Food and Drug Administration Department, Efavirenz
  6. J. Balasubramaniam, K. Bindu, V. U. Rao, D. Ray, R. Haldar and A. W. Brzeczko, Effect of superdisintegrants on dissolution of cationic drugs,(2008) 18-25.
  7. M. S. Gordon, V. S. Rudraraju, K. Dani and Z. T. Chowhan, Effect of the mode of superdisintegrants incorporation on dissolution in wet granulated tablets,(1993) 220-226.
  8. B. Preetha, J. K. Pandit, V. U. Rao, K. Bindu, Y. V. Rajesh and J. Balasubramaniam, Comparative evaluation of mode of incorporation of superdisintegrants on dissolution of model drugs from wet granulated tablets,(2008) 229-236.
  9. Y. S. Yen, C. R. Chen, M. T. Lee and L. C. Chen, Investigation of dissolution enhancement of nifedipine by deposition on superdisintegrants,(1997) 313-317; DOI: 10.3109/03639049709149809.
  10. J. Kukura, J. L. Baxter and F. J. Muzzio, Shear distribution and variability in the USP apparatus 2 under turbulent conditions,(2004) 9-17; DOI: 10.1016/j.ijpharm.2004.03.033.
  11. L. G. McCarthy, C. Kosiol, A. M. Healy, G. Bradley, J. C. Sexton and O. I. Corrigan, Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus,(2005) 1-16.
  12. S. A. Qureshi and J. Shabnam, Cause of high variability in drug dissolution testing and its impact on setting tolerances,(2001) 271-276; DOI: 10.1016/S0928-0987(00)00174-3.
  13. S. A. Qureshi, Developing discriminatory drug dissolution tests and profiles: Some thoughts for consideration on the concept and its interpretation,(2006) 18-23.
  14. M. S. Kim, S. J. Jin, J. S. Kim, H. J. Park, H. S. Song, R. H. H. Neubert and S. J. Hwang, Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process,(2008) 454-465; DOI: 10.1016/j.ejpb.2008.01.007.
DOI: https://doi.org/10.2478/v10007-010-0019-6 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 185 - 195
Published on: Dec 6, 2010
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2010 Yelchuri Rajesh, Jagdish Balasubramaniam, Koduri Bindu, Ramachandran Sridevi, Maroju Swetha, Vinay Rao, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.